Skip to main content

Table 1 The drug resistance rates of Klebsiella pneumoniae by year

From: A 7-year surveillance of the drug resistance in Klebsiella pneumoniae from a primary health care center

Antimicrobial drugs

No. (%)a

2011

2012

2013

2014

2015

2016

2017

NIT

5203 (23.1)

13.7

20.4

24.8

29.6

33.1

12.8

20.7

CZO

4476 (20.3)

25.6

21.6

20.3

20.4

18

18.5

SAM

5195 (20.6)

19.8

20.5

19.8

22.4

18.4

20

22.8

CRO

5204 (18.6)

23.7

21.1

18.6

19.5

15.6

17

17.2

SXT

5205 (17.3)

17.5

19.9

19.2

18

14.5

15.4

17.2

ATM

5202 (10.4)

10.4

11.4

10.1

11.8

9

9.3

10.6

GEN

5044 (10.4)

12.7

11.8

10.5

12.2

8.9

9.6

8.1

CAZ

5189 (7.5)

8.6

9.7

6.1

7.8

7.1

7

6.4

LVX

5202 (5.5)

3.9

7.5

5.8

6.1

3.7

5.2

5.7

CIP

2381 (7.0)

4.1

5.9

7.1

8.3

FEP

5201 (4.7)

4.4

5.3

3.7

5.5

3.4

4.5

6.4

TOB

5202 (3.9)

5.3

4.7

2.9

4.8

2.7

3.9

3.7

TZP

5189 (2.5)

2

2.7

2.1

3.4

1.5

2.4

3.3

IPM

5207 (1.8)

1.5

1.8

1.1

2.7

0.9

2

2.2

AMK

5201 (2.0)

3.5

2.8

1.2

2.3

0.9

1.6

2.1

CTT

5200 (2.0)

2.4

2.4

1.3

2.1

1.5

1.9

2.8

ETP

5141 (1.4)

1.8

3.4

1.8

2.9

0

0

0.1

  1. – Data not available
  2. NIT nitrofurantoin, CZO cefazolin, SAM sulbactam/ampicillin, CRO ceftriaxone, SXT sulfamethoxazole/trimethoprim, ATM aztreonam, GEN gentamycin, CAZ ceftazidime, LVX levofloxacin, CIP ciprofloxacin, FEP cefepime, TOB tobramycin, TZP piperacillin/tazobactam, IPM imipenem, AMK amikacin, CTT cefotetan, ETP ertapenem
  3. aThe total number of strains profiled with each given antibiotic